Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
9.52
-0.27 (-2.76%)
Jan 21, 2025, 4:00 PM EST - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $10.50 million as of January 22, 2025. Its market cap has decreased by -86.35% in one year.
Market Cap
10.50M
Enterprise Value
-10.71M
1-Year Change
-86.35%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $10.50M, a decrease of -91.90%. That is a compound annual growth rate of -54.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 10.50M | -2.36% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |